Hostname: page-component-7479d7b7d-68ccn Total loading time: 0 Render date: 2024-07-10T15:22:44.989Z Has data issue: false hasContentIssue false

SARS-CoV-2: The Lombardy scenario in numbers

Published online by Cambridge University Press:  07 April 2020

Andrea Molinari*
Affiliation:
Department of Health Sciences (DISSAL), University of Genova, Genoa, Italy
Federico Pistoia
Affiliation:
Department of Health Sciences (DISSAL), University of Genova, Genoa, Italy
Giuditta Antonelli
Affiliation:
University of Genova, Genoa, Italy
*
Author for correspondence: Andrea Molinari, Email: a.molinari@live.it
Rights & Permissions [Opens in a new window]

Abstract

Type
Letter to the Editor
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.

To the Editor—On March 11, 2020, the World Health Organization (WHO) declared the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to constitute a pandemic of COVID-19 infectious disease.1 On February 20, 2020, the first national cluster in Italy was identified in the Lombardy region after the diagnosis of SARS-CoV-2 in a 38-year-old man with a severe pneumonia and no relevant exposure history.Reference Onder, Rezza and Brusaferro2 To date, 74,386 SARS-CoV-2 laboratory-confirmed cases have been reported in Italy, with 32,346 cases in Lombardy alone, by far the most affected region.3

Given the extent of the phenomenon, we must urgently consider how the rapid spread of the infection can overload the National Health Service (SSN) and affect the mortality rate. The SSN is regarded as a high-level healthcare service, and it is regionally based.Reference Christopher, Murray and Lauer4 Specifically, Lombardy’s healthcare service is considered a benchmark in terms of quality and efficiency.Reference Bosio and Meroni5

In Lombardy, region of ~10 million people, the pre-crisis total intensive care unit (ICU) bed capacity was of ~720 beds, with a mean occupancy rate in the winter months of 85%–90%.Reference Onder, Rezza and Brusaferro2 To deal with SARS-CoV-2 outbreak, the number of ICU beds has significantly increased, and several departments have been reorganized and dedicated exclusively to COVID-19 patients. Nonetheless, hospitals in Lombardy are dramatically overcrowded with lack of medications, mechanical ventilators, oxygen, and personal protective equipment (PPE).Reference Nacoti, Ciocca and Giupponi6 Clearly, the increased number of cases is posing a serious threat to the entire SSN.Reference Saglietto, D’Ascenzo and Zoccai7

We believe that the following numbers regarding the Lombardy region help to fully measure and elucidate the medical and social impact of SARS-CoV-2 outbreak.

The Italian National Institute of Health (ISS) reported that 4,451 people died in Lombardy due to SARS-CoV-2 complications between January 3 and March 25, 2020.3 In March 2019, there were 9,062 deaths, with 292 deaths per day8; in March 2020, the number of deaths per day was exceeded for 8 days by the number of deaths of confirmed COVID-19 patients alone. The most deadly day was March 21, with 546 daily fatalities due to COVID-19.

To date, 11,262 COVID-19 patients have been hospitalized—1,236 in an ICU. More than 5,000 healthcare workers have been infected across Italy, accounting for 9% of total cases. This number particularly reflects the lack of PPE and the unexpected pressure on the SSN.3

This report highlights how the impact and the consequences of the COVID-19 pandemic have been largely underestimated in Western countries, and it raises concerns about the potential responsiveness of healthcare systems in less-developed countries.

Acknowledgments

Financial support

No financial support was provided relevant to this article.

Conflicts of interest

All authors report no conflicts of interest relevant to this article.

References

WHO virtual press conference on COVID-19—11 March 2020. World Health Organization website. https://www.who.int/docs/default-source/coronaviruse/transcripts/who-audio-emergencies-coronavirus-press-conference-full-and-final-11mar2020.pdf?sfvrsn=cb432bb3_2. Published 2020. Accessed March 23, 2020.Google Scholar
Onder, G, Rezza, G, Brusaferro, S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 2020 [Epub ahead of print]. doi: 10.1001/jama.2020.4683CrossRefGoogle ScholarPubMed
COVID-19 Surveillance Group-Istituto Superiore di Sanità. Epicentro website. https://www.epicentro.iss.it/coronavirus/sars-cov-2-sorveglianza-dati. Published 2020. Accessed March 25, 2020.Google Scholar
Christopher, JL, Murray, JA, Lauer, DB, et al. Measuring overall health system performance for 191 countries. World Health Organization website. https://www.who.int/healthinfo/paper30.pdf. Published 2011. Accessed March 24, 2020.Google Scholar
Bosio, M, Meroni, P. Quality and efficiency of the health service in the Italian region of Lombardy. G Ital Nefrol 2002;19(Spec No. 21):S28S32.Google ScholarPubMed
Nacoti, M, Ciocca, A, Giupponi, A, et al.At the epicenter of the COVID-19 pandemic and humanitarian crises in Italy: changing perspectives on preparation and mitigation. NEJM Cathalyst Innov Care Deliv 2020;1(2) [Epub ahead of print]. doi: 10.1056/CAT.20.0080.Google Scholar
Saglietto, A, D’Ascenzo, F, Zoccai, GB, et al.COVID-19 in Europe: the Italian lesson. Lancet 2020 [Epub ahead of print]. doi: 10.1016/S0140-6736(20)30690-5.CrossRefGoogle ScholarPubMed
Istituto nazionale di statistica (ISTAT), Statistiche demografiche website. http://demo.istat.it/bilmens2019gen/index.html. Published 2019. Accessed March 24, 2020.Google Scholar